Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.005 USD | -2.20% | -6.75% | +18.91% |
15/05 | Wells Fargo Starts WAVE Life Sciences With Overweight Rating, $11 Price Target | MT |
09/05 | Transcript : Wave Life Sciences Ltd., Q1 2024 Earnings Call, May 09, 2024 |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+18.91% | 73Cr | |
+8.38% | 11TCr | |
+10.13% | 10TCr | |
-11.69% | 2.25TCr | |
+2.21% | 2.26TCr | |
-10.88% | 1.8TCr | |
-41.90% | 1.65TCr | |
-16.00% | 1.58TCr | |
+2.28% | 1.35TCr | |
+20.54% | 1.1TCr |
- Stock Market
- Equities
- WVE Stock
- News Wave Life Sciences Ltd.
- Wave Life Sciences Appoints Ken Rhodes as Senior Vice President, Therapeutics Discovery